Filing Details
- Accession Number:
- 0000919574-24-002241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-28 20:29:09
- Reporting Period:
- 2024-03-26
- Accepted Time:
- 2024-03-28 20:29:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1860782 | 2Seventy Bio Inc. | TSVT | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534260 | Casdin Partners Gp, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | Yes | No | No | No | |
| 1534261 | Casdin Capital, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | Yes | No | No | No | |
| 1534264 | Eli Casdin | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | Yes | No | No | No | |
| 1534265 | Casdin Partners Master Fund, L.p. | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-03-26 | 40,000 | $5.10 | 2,000,000 | No | 4 | P | Indirect | See footnote. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | 16,600 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $4.9 to $5.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- This restricted stock unit award vests ratable over three years in annual installments with the first installment vesting on March 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
- The securities are owned directly by Eli Casdin.
Billionaire Hedge Funds
